| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.5M | +12.5% | -3.3% |
| Cost of Revenue | $2.2M | +14.5% | -6.0% |
| Gross Profit | $378K | +2.6% | +15.7% |
| R&D Expense | $15K | +18.5% | +42.5% |
| SG&A Expense | $446K | -13.8% | -79.1% |
| Operating Income | -$703K | -14.9% | +47.5% |
| Pre-tax Income | -$709K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $1.5M | -17.8% | — |
| Inventory | $1.0M | -17.1% | -27.5% |
| Current Assets | $5.6M | -11.8% | -20.1% |
| Total Assets | $7.6M | -19.1% | -30.7% |
| Current Liabilities | $678K | -61.4% | -52.1% |
| Total Liabilities | $805K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.8M | — | — |
| Capital Expenditures | $36K | — | — |
| Investing Cash Flow | $950K | — | — |
| Financing Cash Flow | $32K | — | — |
| Free Cash Flow | -$2.8M | — | — |
| -15.1% |
| +47.2% |
| Income Tax | $0 | — | -100.0% |
| Net Income | -$709K | -15.1% | +47.3% |
| EPS (Diluted) | -$0.40 | -15.2% | +47.3% |
| -57.6% |
| -49.9% |
| Stockholders' Equity | $6.8M | -9.4% | -27.4% |